Data from biotech company Moderna Inc shows early promising results from their COVID-19 vaccine.
According to Reuters, Moderna's vaccine is the first to be tested in the United States.
Studies showed that it produced protective antibodies in a very small group of healthy volunteers.
The data are from a limited study of eight people who took part in a safety trial that kicked off in March.
The Moderna vaccine is one of more than 100 being investigated.
